in Newswire April 1, 2019

AbbVie, Amgen Allegedly Conspired to Suppress Competition for Humira

by Nadia Abbas

Last Updated on April 1, 2019

Welfare Plan of The International Union of Operating Engineers Locals 137, 137A, 137B, 137C, 137R v. Abbvie, Inc. et al

Filed: April 1, 2019 § 1:19cv2226

A lawsuit focuses on three pharmaceutical companies’ alleged conspiracy to maintain a monopoly over the market for arthritis treatment Humira.

Last Updated on April 1, 2019 — 10:04 AM

Nadia Abbas

nadia@classaction.org

Nadia is a junior content writer for ClassAction.org.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.